Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 740

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Epidemiology of pancreatic cancer: an overview

Raimondi, Sara, Maisonneuve, Patrick, Lowenfels, Albert B.·2009·Nature Reviews Gastroenterology & Hepatology
DOI 10.1038/nrgastro.2009.177
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/nrgastro.2009.177

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Research works printed but not linked: 116

  1. Parkin, D. M., Bray, F., Ferlay, J. & Pisani, P. Estimating the world cancer burden: Globocan 2000. Int. J. Cancer 94, 153–156 (2001). · DOI · Paper page
  2. Carpelan-Holmstrom, M. et al. Does anyone survive pancreatic ductal adenocarcinoma? A nationwide study re-evaluating the data of the Finnish Cancer Registry. Gut 54, 385–387 (2005). · DOI · Paper page
  3. Kinoshita, S., Wagatsuma, Y. & Okada, M. Geographical distribution for malignant neoplasm of the pancreas in relation to selected climatic factors in Japan. Int. J. Health Geogr. 6, 34 (2007). · DOI
  4. Giovannucci, E. et al. Prospective study of predictors of vitamin D status and cancer incidence and mortality in men. J. Natl Cancer Inst. 98, 451–459 (2006). · DOI · Paper page
  5. Grant, W. B. & Mohr, S. B. Ecological studies of ultraviolet B, vitamin D and cancer since 2000. Ann. Epidemiol. 19, 446–454 (2009). · DOI
  6. Parkin, D. M., Bray, F., Ferlay, J. & Pisani, P. Global cancer statistics, 2002. CA Cancer J. Clin. 55, 74–108 (2005). · DOI · Paper page
  7. Raimondi, S., Maisonneuve, P., Lohr, J. M. & Lowenfels, A. B. Early onset pancreatic cancer: evidence of a major role for smoking and genetic factors. Cancer Epidemiol. Biomarkers Prev. 16, 1894–1897 (2007). · DOI
  8. Deutsch, M., Rosenstein, M. M. & Ramanathan, R. K. Pancreatic cancer in a young adult after treatment for Hodgkin's disease. Clin. Oncol. (R. Coll. Radiol.) 11, 280–282 (1999). · doi:10.1053/clon.1999.9065
  9. Wahi, M. M., Shah, N., Schrock, C. E., Rosemurgy, A. S. & Goldin, S. B. Reproductive factors and risk of pancreatic cancer in women: a review of the literature. Ann. Epidemiol. 19, 103–111 (2009). · DOI
  10. Horner, M. J. et al. (Eds) SEER Cancer Statistics Review, 1975–2006, National Cancer Institute [online], (2009).
  11. Silverman, D. T. et al. Why do Black Americans have a higher risk of pancreatic cancer than White Americans? Epidemiology 14, 45–54 (2003). · DOI
  12. Muscat, J. E., Djordjevic, M. V., Colosimo, S., Stellman S. D. & Richie, J. P. J. Racial differences in exposure and glucuronidation of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK). Cancer 103, 1420–1426 (2005). · DOI
  13. Jiao, L. et al. A combined healthy lifestyle score and risk of pancreatic cancer in a large cohort study. Arch. Intern. Med. 169, 764–770 (2009). · DOI
  14. Iodice, S., Gandini, S., Maisonneuve, P. & Lowenfels, A. B. Tobacco and the risk of pancreatic cancer: a review and meta-analysis. Langenbecks Arch. Surg. 393, 535–545 (2008). · DOI · Paper page
  15. Boffetta, P., Hecht, S., Gray, N., Gupta, P. & Straif, K. Smokeless tobacco and cancer. Lancet Oncol. 9, 667–675 (2008). · DOI · Paper page
  16. Rohrmann, S. et al. Ethanol intake and the risk of pancreatic cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC). Cancer Causes Control 20, 785–794 (2009). · DOI
  17. Jiao, L. et al. Alcohol use and risk of pancreatic cancer: the NIH-AARP Diet and Health Study. Am. J. Epidemiol. 169, 1043–1051 (2009). · DOI
  18. Genkinger, J. M. et al. Alcohol intake and pancreatic cancer risk: a pooled analysis of fourteen cohort studies. Cancer Epidemiol. Biomarkers Prev. 18, 765–776 (2009). · DOI
  19. Vrieling, A. et al. Fruit and vegetable consumption and pancreatic cancer risk in the European Prospective Investigation into Cancer and Nutrition. Int. J. Cancer 124, 1926–1934 (2009). · DOI
  20. Nothlings, U., Murphy, S. P., Wilkens, L. R., Henderson, B. E. & Kolonel, L. N. Flavonols and pancreatic cancer risk: the multiethnic cohort study. Am. J. Epidemiol. 166, 924–931 (2007). · DOI · Paper page
  21. Stolzenberg-Solomon, R. Z. et al. Dietary and other methyl-group availability factors and pancreatic cancer risk in a cohort of male smokers. Am. J. Epidemiol. 153, 680–687 (2001). · DOI
  22. Larsson, S. C., Hakansson, N., Giovannucci, E. & Wolk, A. Folate intake and pancreatic cancer incidence: a prospective study of Swedish women and men. J. Natl Cancer Inst. 98, 407–413 (2006). · DOI
  23. Giovannucci, E. Vitamin D and cancer incidence in the Harvard cohorts. Ann. Epidemiol. 19, 84–88 (2009). · DOI
  24. Gong, Z., Holly, E. A. & Bracci, P. M. Intake of folate, vitamins B(6), B (12) and methionine and risk of pancreatic cancer in a large population-based case-control study. Cancer Causes Control doi: 10.1007/s10552-009-9352–9359 · doi:10.1007/s10552-009-9352-9359
  25. Larsson, S. C., Giovannucci, E. & Wolk, A. Methionine and vitamin B6 intake and risk of pancreatic cancer: a prospective study of Swedish women and men. Gastroenterology 132, 113–118 (2007). · DOI
  26. Reeves, G. K. et al. Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study. BMJ 335, 1134 (2007). · DOI · Paper page
  27. Fryzek, J. P., Schenk, M., Kinnard, M., Greenson, J. K. & Garabrant, D. H. The association of body mass index and pancreatic cancer in residents of southeastern Michigan, 1996–1999. Am. J. Epidemiol. 162, 222–228 (2005). · DOI
  28. Patel, A. V. et al. Obesity, recreational physical activity, and risk of pancreatic cancer in a large, U. S. Cohort. Cancer Epidemiol. Biomarkers Prev. 14, 459–466 (2005). · DOI · Paper page
  29. Berrington de González, A., Sweetland, S. & Spencer, E. A meta-analysis of obesity and the risk of pancreatic cancer. Br. J. Cancer 89, 519–523 (2003). · DOI · Paper page
  30. Khasawneh, J. et al. Inflammation and mitochondrial fatty acid beta-oxidation link obesity to early tumor promotion. Proc. Natl Acad. Sci. USA 106, 3354–3359 (2009). · DOI
  31. Jiao, L. et al. Glycemic index, carbohydrates, glycemic load, and the risk of pancreatic cancer in a prospective cohort study. Cancer Epidemiol. Biomarkers Prev. 18, 1144–1151 (2009). · DOI
  32. Bao, Y. et al. Added sugar and sugar-sweetened foods and beverages and the risk of pancreatic cancer in the National Institutes of Health-AARP Diet and Health Study. Am. J. Clin. Nutr. 88, 431–440 (2008). · DOI
  33. Heinen, M. M. et al. Glycemic load, glycemic index, and pancreatic cancer risk in the Netherlands Cohort Study. Am. J. Clin. Nutr. 87, 970–977 (2008). · DOI
  34. Gnagnarella, P., Gandini, S., La Vecchia, C. & Maisonneuve, P. Glycemic index, glycemic load, and cancer risk: a meta-analysis. Am. J. Clin. Nutr. 87, 1793–1801 (2008). · DOI
  35. Larsson, S. C., Orsini, N. & Wolk, A. Body mass index and pancreatic cancer risk: A meta-analysis of prospective studies. Int. J. Cancer 120, 1993–1998 (2007). · DOI · Paper page
  36. Li, D. et al. Body mass index and risk, age of onset, and survival in patients with pancreatic cancer. JAMA 301, 2553–1562 (2209). · DOI · Paper page
  37. Berrington de González, A. et al. Anthropometry, physical activity, and the risk of pancreatic cancer in the European prospective investigation into cancer and nutrition. Cancer Epidemiol. Biomarkers Prev. 15, 879–885 (2006). · DOI
  38. Stolzenberg-Solomon, R. Z. et al. Adiposity, physical activity, and pancreatic cancer in the National Institutes of Health-AARP Diet and Health Cohort. Am. J. Epidemiol. 167, 586–597 (2008). · DOI
  39. Calton, B. A. et al. A prospective study of physical activity and the risk of pancreatic cancer among women (United States). BMC Cancer 8, 63 (2008). · DOI
  40. Stevens, R. J. et al. Factors associated with incident and fatal pancreatic cancer in a cohort of middle-aged women. Int. J. Cancer 124, 2400–2405 (2009). · DOI
  41. Anderson, K. E., Johnson, T. W., Lazovich, D. & Folsom, A. R. Association between nonsteroidal anti-inflammatory drug use and the incidence of pancreatic cancer. J. Natl Cancer Inst. 94, 1168–1171 (2002). · DOI
  42. Capurso, G. et al. Meta-analysis: the use of non-steroidal anti-inflammatory drugs and pancreatic cancer risk for different exposure categories. Aliment. Pharmacol. Ther. 26, 1089–1099 (2007). · DOI
  43. Coogan, P. F. et al. Nonsteroidal anti-inflammatory drugs and risk of digestive cancers at sites other than the large bowel. Cancer Epidemiol. Biomarkers Prev. 9, 119–123 (2000).
  44. Jacobs, E. J. et al. Aspirin use and pancreatic cancer mortality in a large United States cohort. J. Natl Cancer Inst. 96, 524–528 (2004). · DOI
  45. Larsson, S. C., Giovannucci, E., Bergkvist, L. & Wolk, A. Aspirin and nonsteroidal anti-inflammatory drug use and risk of pancreatic cancer: a meta-analysis. Cancer Epidemiol. Biomarkers Prev. 15, 2561–2564 (2006). · DOI
  46. Menezes, R. J., Huber, K. R., Mahoney, M. C. & Moysich, K. B. Regular use of aspirin and pancreatic cancer risk. BMC Public Health 2, 18 (2002). · DOI
  47. Schernhammer, E. S. et al. A prospective study of aspirin use and the risk of pancreatic cancer in women. J. Natl Cancer Inst. 96, 22–28 (2004). · DOI
  48. Sumi, S. et al. Inhibition of pancreatic adenocarcinoma cell growth by lovastatin. Gastroenterology 103, 982–989 (1992). · DOI
  49. Bonovas, S., Filioussi, K. & Sitaras, N. M. Statins are not associated with a reduced risk of pancreatic cancer at the population level, when taken at low doses for managing hypercholesterolemia: evidence from a meta-analysis of 12 studies. Am. J. Gastroenterol. 103, 2646–2651 (2008). · DOI
  50. Luo, J. et al. Body mass index, physical activity and the risk of pancreatic cancer in relation to smoking status and history of diabetes: a large-scale population-based cohort study in Japan—the JPHC study. Cancer Causes Control 18, 603–612 (2007). · DOI
  51. Hassan, M. M. et al. Risk factors for pancreatic cancer: case-control study. Am. J. Gastroenterol. 102, 2696–2707 (2007). · DOI · Paper page
  52. Huxley, R., Ansary-Moghaddam, A., Berrington de González, A., Barzi, F. & Woodward, M. Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies. Br. J. Cancer 92, 2076–2083 (2005). · DOI · Paper page
  53. Chari, S. T. et al. Pancreatic cancer-associated diabetes mellitus: prevalence and temporal association with diagnosis of cancer. Gastroenterology 134, 95–101 (2008). · DOI · Paper page
  54. Li, D., Yeung, S. C., Hassan, M. M., Konopleva, M. & Abbruzzese, J. L. Antidiabetic therapies affect risk of pancreatic cancer. Gastroenterology 137, 482–488 (2009). · DOI · Paper page
  55. Lowenfels, A. B. et al. Pancreatitis and the risk of pancreatic cancer. International Pancreatitis Study Group. N. Engl. J. Med. 328, 1433–1437 (1993). · DOI · Paper page
  56. Malka, D. et al. Risk of pancreatic adenocarcinoma in chronic pancreatitis. Gut 51, 849–852 (2002). · DOI · Paper page
  57. Hart, A. R., Kennedy, H. & Harvey, I. Pancreatic cancer: a review of the evidence on causation. Clin. Gastroenterol. Hepatol. 6, 275–282 (2008). · DOI
  58. Lowenfels, A. B. et al. Hereditary pancreatitis and the risk of pancreatic cancer. International Hereditary Pancreatitis Study Group. J. Natl Cancer Inst. 89, 442–446 (1997). · DOI · Paper page
  59. Howes, N. et al. Clinical and genetic characteristics of hereditary pancreatitis in Europe. Clin. Gastroenterol. Hepatol. 2, 252–261 (2004). · DOI · Paper page
  60. Rebours, V. et al. Risk of pancreatic adenocarcinoma in patients with hereditary pancreatitis: a national exhaustive series. Am. J. Gastroenterol. 103, 111–119 (2008). · DOI · Paper page
  61. Anderson, L. N., Cotterchio, M. & Gallinger, S. Lifestyle, dietary, and medical history factors associated with pancreatic cancer risk in Ontario, Canada. Cancer Causes Control doi: 10.1007/s10552-009-9303–9305 · doi:10.1007/s10552-009-9303-9305
  62. Gandini, S., Lowenfels, A. B., Jaffee, E. M., Armstrong, T. D. & Maisonneuve, P. Allergies and the risk of pancreatic cancer: a meta-analysis with review of epidemiology and biological mechanisms. Cancer Epidemiol. Biomarkers Prev. 14, 1908–1916 (2005). · DOI
  63. Olson, S. H. et al. Allergies, variants in IL-4 and IL-4R alpha genes, and risk of pancreatic cancer. Cancer Detect. Prev. 31, 345–351 (2007). · doi:10.1016/j.cdp.2007.10.002
  64. Turner, M. C., Chen, Y., Krewski, D. & Ghadirian, P. An overview of the association between allergy and cancer. Int. J. Cancer 118, 3124–3132 (2006). · DOI
  65. Sherman, P. W., Holland, E. & Sherman, J. S. Allergies: their role in cancer prevention. Q. Rev. Biol. 83, 339–362 (2008). · DOI
  66. Farrow, D. C. & Davis, S. Risk of pancreatic cancer in relation to medical history and the use of tobacco, alcohol and coffee. Int. J. Cancer 45, 816–820 (1990). · DOI
  67. Stolzenberg-Solomon, R. Z., Pietinen, P., Taylor, P. R., Virtamo, J. & Albanes, D. A. prospective study of medical conditions, anthropometry, physical activity, and pancreatic cancer in male smokers (Finland). Cancer Causes Control 13, 417–426 (2002). · DOI
  68. Meyer, M. S., Joshipura, K., Giovannucci, E. & Michaud, D. S. A review of the relationship between tooth loss, periodontal disease, and cancer. Cancer Causes Control 19, 895–907 (2008). · DOI · Paper page
  69. El-Serag, H. B. et al. Risk of hepatobiliary and pancreatic cancers after hepatitis C virus infection: A population-based study of U. S. veterans. Hepatology 49, 116–123 (2009). · DOI · Paper page
  70. Hassan, M. M. et al. Association between hepatitis B virus and pancreatic cancer. J. Clin. Oncol. 26, 4557–4562 (2008). · DOI
  71. Raderer, M. et al. Association between Helicobacter pylori infection and pancreatic cancer. Oncology 55, 16–19 (1998). · DOI
  72. Stolzenberg-Solomon, R. Z. et al. Helicobacter pylori seropositivity as a risk factor for pancreatic cancer. J. Natl Cancer Inst. 93, 937–941 (2001). · DOI · Paper page
  73. Lindkvist, B., Johansen, D., Borgstrom, A. & Manjer, J. A prospective study of Helicobacter pylori in relation to the risk for pancreatic cancer. BMC Cancer 8, 321 (2008). · DOI
  74. Wolpin, B. M. et al. ABO blood group and the risk of pancreatic cancer. J. Natl Cancer Inst. 101, 424–431 (2009). · DOI · Paper page
  75. Landi, S. Genetic predisposition and environmental risk factors to pancreatic cancer: A review of the literature. Mutat. Res. 681, 299–307 (2009). · DOI
  76. Goldstein, A. M., Struewing, J. P., Fraser, M. C., Smith, M. W. & Tucker, M. A. Prospective risk of cancer in CDKN2A germline mutation carriers. J. Med. Genet. 41, 421–424 (2004). · DOI
  77. Vasen, H. F. et al. Risk of developing pancreatic cancer in families with familial atypical multiple mole melanoma associated with a specific 19 deletion of p16 (p16-Leiden). Int. J. Cancer 87, 809–811 (2000). · DOI · Paper page
  78. De Snoo, F. A. et al. Increased risk of cancer other than melanoma in CDKN2A founder mutation (p16-Leiden)-positive melanoma families. Clin. Cancer Res. 14, 7151–7157 (2008). · DOI · Paper page
  79. Goldstein, A. M. et al. High-risk melanoma susceptibility genes and pancreatic cancer, neural system tumors, and uveal melanoma across GenoMEL. Cancer Res. 66, 9818–9828 (2006). · DOI · Paper page
  80. Howes, N. et al. Clinical and genetic characteristics of hereditary pancreatitis in Europe. Clin. Gastroenterol. Hepatol. 2, 252–261 (2004). · DOI · Paper page
  81. Lowenfels, A. B., Maisonneuve, P., Whitcomb, D. C., Lerch, M. M. & DiMagno, E. P. Cigarette smoking as a risk factor for pancreatic cancer in patients with hereditary pancreatitis. JAMA 286, 169–170 (2001). · DOI · Paper page
  82. Giardiello, F. M. et al. Very high risk of cancer in familial Peutz–Jeghers syndrome. Gastroenterology 119, 1447–1453 (2000). · DOI · Paper page
  83. Hearle, N. et al. Frequency and spectrum of cancers in the Peutz–Jeghers syndrome. Clin. Cancer Res. 12, 3209–3215 (2006). · DOI · Paper page
  84. Lim, W. et al. Relative frequency and morphology of cancers in STK11 mutation carriers. Gastroenterology 126, 1788–1794 (2004). · DOI · Paper page
  85. Pogue-Geile, K. L. et al. Palladin mutation causes familial pancreatic cancer and suggests a new cancer mechanism. PLoS Med. 3, e516 (2006). · DOI
  86. Klein, A. P. et al. Absence of deleterious palladin mutations in patients with familial pancreatic cancer. Cancer Epidemiol. Biomarkers Prev. 18, 1328–1330 (2009). · DOI
  87. McWilliams, R. et al. Cystic fibrosis transmembrane regulator gene carrier status is a risk factor for young onset pancreatic adenocarcinoma. Gut 54, 1661–1662 (2005). · DOI
  88. Maisonneuve, P., Marshall, B. C. & Lowenfels, A. B. Risk of pancreatic cancer in patients with cystic fibrosis. Gut 56, 1327–1328 (2007). · DOI
  89. Malats, N. et al. Cystic fibrosis transmembrane regulator (CFTR) DeltaF508 mutation and 5T allele in patients with chronic pancreatitis and exocrine pancreatic cancer. PANKRAS II Study Group. Gut 48, 70–74 (2001). · DOI
  90. van Asperen, C. J. et al. Cancer risks in BRCA2 families: estimates for sites other than breast and ovary. J. Med. Genet. 42, 711–719 (2005). · DOI · Paper page
  91. Risch, H. A. et al. Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin-cohort study in Ontario, Canada. J. Natl Cancer Inst. 98, 1694–1706 (2006). · DOI · Paper page
  92. Couch, F. J. et al. The prevalence of BRCA2 mutations in familial pancreatic cancer. Cancer Epidemiol. Biomarkers Prev. 16, 342–346 (2007). · DOI · Paper page
  93. Ferrone, C. R. et al. BRCA germline mutations in Jewish patients with pancreatic adenocarcinoma. J. Clin. Oncol. 27, 433–438 (2009). · DOI
  94. Cho, J. H., Bang, S., Park, S. W., Chung, J. B. & Song, S. Y. BRCA2 mutations as a universal risk factor for pancreatic cancer has a limited role in Korean ethnic group. Pancreas 36, 337–340 (2008). · DOI
  95. Real, F. X. et al. Family history of cancer and germline BRCA2 mutations in sporadic exocrine pancreatic cancer. Gut 50, 653–657 (2002). · DOI
  96. Giardiello, F. M. et al. Increased risk of thyroid and pancreatic carcinoma in familial adenomatous polyposis. Gut 34, 1394–1396 (1993). · DOI · Paper page
  97. Kleihues, P., Schauble, B., zur Hausen, A., Esteve, J. & Ohgaki, H. Tumors associated with p53 germline mutations: a synopsis of 91 families. Am. J. Pathol. 150, 1–13 (1997).
  98. Geary, J. et al. Gene-related cancer spectrum in families with hereditary non-polyposis colorectal cancer (HNPCC). Fam. Cancer 7, 163–172 (2008). · DOI
  99. Su, G. H. et al. Germline and somatic mutations of the STK11/LKB1 Peutz–Jeghers gene in pancreatic and biliary cancers. Am. J. Pathol. 154, 1835–1840 (1999). · DOI · Paper page
  100. Blackford, A. et al. Genetic mutations associated with cigarette smoking in pancreatic cancer. Cancer Res. 69, 3681–3688 (2009). · DOI · Paper page
  101. Crous-Bou, M. et al. Lifetime history of alcohol consumption and K-ras mutations in pancreatic ductal adenocarcinoma. Environ. Mol. Mutagen. 50, 421–430 (2009). · DOI
  102. Morales, E. et al. Food and nutrient intakes and K-ras mutations in exocrine pancreatic cancer. J. Epidemiol. Community Health 61, 641–649 (2007). · DOI
  103. Jiao, L. et al. Glutathione S-transferase gene polymorphisms and risk and survival of pancreatic cancer. Cancer 109, 840–848 (2007). · doi:10.1002/cncr.22468
  104. Li, D. et al. Polymorphisms of cytochrome P4501A2 and N-acetyltransferase genes, smoking, and risk of pancreatic cancer. Carcinogenesis 27, 103–111 (2006). · DOI
  105. Ayaz, L., Ercan, B., Dirlik, M., Atik, U. & Tamer, L. The association between N-acetyltransferase 2 gene polymorphisms and pancreatic cancer. Cell. Biochem. Funct. 26, 329–333 (2008). · DOI
  106. Ockenga, J., Vogel, A., Teich, N., Keim, V., Manns, M. P. & Strassburg, C. P. UDP glucuronosyltransferase (UGT1A7) gene polymorphisms increase the risk of chronic pancreatitis and pancreatic cancer. Gastroenterology 124, 1802–1808 (2003). · DOI
  107. Suzuki, H. et al. Interaction of the cytochrome P4501A2, SULT1A1 and NAT gene polymorphisms with smoking and dietary mutagen intake in modification of the risk of pancreatic cancer. Carcinogenesis 29, 1184–1191 (2008). · DOI
  108. Duell, E. J. et al. A population-based, case-control study of polymorphisms in carcinogen-metabolizing genes, smoking, and pancreatic adenocarcinoma risk. J. Natl Cancer Inst. 94, 297–306 (2002). · DOI
  109. Li, D. et al. 5, 10-Methylenetetrahydrofolate reductase polymorphisms and the risk of pancreatic cancer. Cancer Epidemiol. Biomarkers Prev. 14, 1470–1476 (2005). · doi:10.1158/1055-9965.epi-04-0894
  110. Wang, L. et al. Genetic polymorphisms in methylenetetrahydrofolate reductase and thymidylate synthase and risk of pancreatic cancer. Clin. Gastroenterol. Hepatol. 3, 743–751 (2005). · DOI
  111. Nisevic, I. et al. MTHFR C677T polymorphism in chronic pancreatitis and pancreatic adenocarcinoma. Cell. Biochem. Funct. 26, 659–663 (2008). · doi:10.1002/cbf.1487
  112. Suzuki, T. et al. Alcohol drinking and one-carbon metabolism-related gene polymorphisms on pancreatic cancer risk. Cancer Epidemiol. Biomarkers Prev. 17, 2742–2747 (2008). · DOI
  113. Li, D. et al. DNA repair gene polymorphisms and risk of pancreatic cancer. Clin. Cancer Res. 15, 740–746 (2009). · DOI
  114. McWilliams, R. R. et al. Polymorphisms in DNA repair genes, smoking, and pancreatic adenocarcinoma risk. Cancer Res. 68, 4928–4935 (2008). · DOI
  115. Duell, E. J. et al. Detecting pathway-based gene-gene and gene–environment interactions in pancreatic cancer. Cancer Epidemiol. Biomarkers Prev. 17, 1470–1479 (2008). · DOI
  116. Jiao, L. et al. XRCC2 and XRCC3 gene polymorphism and risk of pancreatic cancer. Am. J. Gastroenterol. 103, 360–367 (2008). · DOI

Cited by

See all 740

Metadata

Authors
Raimondi, S., Maisonneuve, P., & Lowenfels, A. B.
Venue
Nature Reviews Gastroenterology & Hepatology
Publisher
Springer Science and Business Media LLC
Published
2009-10-06
Volume
6
Issue
12
Pages
699-708
ISSN
  • 1759-5045 (ISSN-L)
  • 1759-5053
DOI
10.1038/nrgastro.2009.177
OpenAlex
W1976284083
Cited by
740
References
8
FWCI
2.68
Type
journal article
Language
en
Open access
closed
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Epidemiology of pancreatic cancer: an overview. https://app.cochat.ai/papers/10.1038/nrgastro.2009.177
The paper
Raimondi, S., Maisonneuve, P., & Lowenfels, A. B. (2009). Epidemiology of pancreatic cancer: an overview. Nature Reviews Gastroenterology & Hepatology. https://doi.org/10.1038/nrgastro.2009.177

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.